Page 35 - Mary Ann Liebert, Inc

Medical research

Multichannel bioreactor for lung regeneration analysis

New strides are being made toward the ex vivo growth of human lungs. In a new article published in Tissue Engineering, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, researchers report the development of ...

Diseases, Conditions, Syndromes

Targeted antisense oligonucleotide drug tested in humans

A first-in-human study with a new class of antisense oligonucleotide therapeutics showed the ability to target the RNA-silencing drug to the liver, resulting in improved potency and safety at therapeutic doses. The design ...

page 35 from 40